CS
OPTR

Credit Suisse’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Credit Suisse’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-31,123
Closed -$392K – 4850
2013
Q3 		$392K Sell
31,123
-114,376
-79% -$1.52M ﹤0.01% 3632
2013
Q2 		$2.1M Buy
+145,499
New +$2.12M ﹤0.01% 2226

Credit Suisse's OPTR Position: Q4 2013 in Review

Credit Suisse sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 31,123 shares — an estimated $392K sold.

Credit Suisse first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $2.1M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Credit Suisse reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Credit Suisse sold 31,123 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $392K.
  • Credit Suisse first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Credit Suisse's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.1M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Credit Suisse's 13F filing for Q4 2013, filed 14 Feb 2014.